Back to search

Article

Durable Disease Control after Sequential Anlotinib Maintenance Therapy Following Local Radiotherapy in a Patient with Platinum-Refractory Recurrent Ovarian Clear Cell Carcinoma: A Case Report and Literature Review

2026-08-10

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Ovarian clear cell carcinoma (OCCC) is a distinct histological subtype of epithelial ovarian cancer. Its incidence is substantially higher in Asian populations than in Western populations. The clinical management of OCCC remains challenging, particularly in patients with advanced or recurrent disease, who generally have a poor prognosis. Advanced-stage OCCC s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
059ab118-8415-51cf-a517-631b59bb16aa
DOI
10.21203/rs.3.rs-10255047/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Durable Disease Control after Sequential Anlotinib Maintenance Therapy Following Local Radiotherapy in a Patient with Platinum-Refractory Recurrent Ovarian Clear Cell Carcinoma: A Case Report and Literature ReviewDOI 10.21203/rs.3.rs-10255047/v1
Genetic characteristics of platinum-sensitive ovarian clear cell carcinomaSemantic proximity
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report.Semantic proximity
A Phase I Dose-Escalation Study of Lobaplatin Combined with Paclitaxel in Platinum-Sensitive Recurrent Ovarian Epithelial Carcinoma: Safety, Tolerability, and Preliminary Efficacy AnalysisSemantic proximity
Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.Semantic proximity
Apatinib in Treating Clinical and Biochemical Recurrent Ovarian CancerSemantic proximity
Genetic characteristics of platinum-sensitive ovarian clear cell carcinoma.Semantic proximity
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)Semantic proximity
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review.Semantic proximity
Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival.Semantic proximity
Advanced ovarian clear cell carcinoma with RAD50 mutation treated by PARP inhibitor pamiparib combined with anti-angiogenesis therapy: a case report.Semantic proximity
Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR.Semantic proximity
Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer.Semantic proximity
Select a neighboring publication to make it the new centre.